-
1
-
-
0019986952
-
Pharmaceutical and biological availability of commercial preparations of furosemide
-
Stüber, A., Mutschler, E., Steinbach, D., Pharmaceutical and biological availability of commercial preparations of furosemide. Arzneim.-Forsch./Drug Res. 32 (I), 693 (1982)
-
(1982)
Arzneim.-Forsch./Drug Res.
, vol.32
, Issue.1
, pp. 693
-
-
Stüber, A.1
Mutschler, E.2
Steinbach, D.3
-
2
-
-
0020583238
-
Bioavailability of two preparations of furosemide and their pharmacological activity in normal volunteers
-
Ogata, H., Zugarni, S., Ejima, A. et al., Bioavailability of two preparations of furosemide and their pharmacological activity in normal volunteers. Eur. J. Clin. Pharmacol. 24, 791 (1983)
-
(1983)
Eur. J. Clin. Pharmacol.
, vol.24
, pp. 791
-
-
Ogata, H.1
Zugarni, S.2
Ejima, A.3
-
3
-
-
0021243165
-
Comparative bioavailability of two furosemide formulations in humans
-
Martin, B. K., Uihlein, M., Ings, R. M. J. et al., Comparative bioavailability of two furosemide formulations in humans. J. Pharm. Sci. 73, 437 (1984)
-
(1984)
J. Pharm. Sci.
, vol.73
, pp. 437
-
-
Martin, B.K.1
Uihlein, M.2
Ings, R.M.J.3
-
4
-
-
0028948839
-
A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
-
Amidon, G. L., Lenneräs, H., Shah, V. P. et al., A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12, 413 (1995)
-
(1995)
Pharm. Res.
, vol.12
, pp. 413
-
-
Amidon, G.L.1
Lenneräs, H.2
Shah, V.P.3
-
5
-
-
0031704891
-
Assesment of pharmaceutical quality of furosemide tablets from multinational markets
-
Qureshi, S. A., McGilveray, I. J., Assesment of pharmaceutical quality of furosemide tablets from multinational markets. Drug Dev. Ind. Pharm. 24, 995 (1998)
-
(1998)
Drug Dev. Ind. Pharm.
, vol.24
, pp. 995
-
-
Qureshi, S.A.1
McGilveray, I.J.2
-
6
-
-
0038475169
-
-
National Formulary 19 The United States Pharmacopeial Convention Inc., Rockville, MD
-
United States Pharmacopeia 24, National Formulary 19 The United States Pharmacopeial Convention Inc., Rockville, MD (2000)
-
(2000)
United States Pharmacopeia
, vol.24
-
-
-
7
-
-
2342652446
-
Mathematical comparison of dissolution profiles
-
Moore, J. W., Flanner, H. H., Mathematical comparison of dissolution profiles. Pharm. Technol. 20, 64 (1996)
-
(1996)
Pharm. Technol.
, vol.20
, pp. 64
-
-
Moore, J.W.1
Flanner, H.H.2
-
8
-
-
0003419264
-
-
The European Agency for the Evaluation of Medicinal Products. Human Medicines Evaluation Unit (CPMP/EWP/QWP/1401/98/Draft)
-
CPMP (Committee for Propietary Medicinal Products). Note for Guidance on the Investigation of Bioavailability and Bioequivalence. Draft document. The European Agency for the Evaluation of Medicinal Products. Human Medicines Evaluation Unit (CPMP/EWP/QWP/1401/98/Draft) (1998)
-
(1998)
Note for Guidance on the Investigation of Bioavailability and Bioequivalence. Draft Document
-
-
-
9
-
-
0029128554
-
Reference tables for the intrasubject coefficient of variation in bioequivalence studies
-
Steinijans, V. W., Sauter, R., Hauschke, D. et al., Reference tables for the intrasubject coefficient of variation in bioequivalence studies. Int. J. Clin. Pharmacol. Ther. 33, 427 (1995)
-
(1995)
Int. J. Clin. Pharmacol. Ther.
, vol.33
, pp. 427
-
-
Steinijans, V.W.1
Sauter, R.2
Hauschke, D.3
-
10
-
-
0034469255
-
Bioanalytical method validation. A revisit with a decade of progress
-
Workshop/Conference Report
-
Shah, V. P., Midha, K. K., Findlay, J. W. A. et al., Bioanalytical method validation. A revisit with a decade of progress. Workshop/Conference Report. Pharm. Res. 17, 1551 (2000)
-
(2000)
Pharm. Res.
, vol.17
, pp. 1551
-
-
Shah, V.P.1
Midha, K.K.2
Findlay, J.W.A.3
-
13
-
-
0023615056
-
A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability
-
Schuirmann, D. J., A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharmacokin. Biopharm. 15, 657 (1987)
-
(1987)
J. Pharmacokin. Biopharm.
, vol.15
, pp. 657
-
-
Schuirmann, D.J.1
-
14
-
-
0026832969
-
On the assesment of bioequivalence in a two-period crossover design
-
Wijnand, H. P., On the assesment of bioequivalence in a two-period crossover design. Comput. Methods Programs Biomed. 37, 151 (1992)
-
(1992)
Comput. Methods Programs Biomed.
, vol.37
, pp. 151
-
-
Wijnand, H.P.1
-
15
-
-
0020662337
-
Statistical analysis of bioavailability studies: Parametric and nonparametric confidence intervals
-
Steinijans, V. W., Diletti, E., Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervals. Eur. J. Clin. Pharmacol. 24, 127 (1983)
-
(1983)
Eur. J. Clin. Pharmacol.
, vol.24
, pp. 127
-
-
Steinijans, V.W.1
Diletti, E.2
-
16
-
-
0021924569
-
Generalization of distribution-flee confidence intervals for bioavailability ratios
-
Steinijans, V. W., Diletti, E., Generalization of distribution-flee confidence intervals for bioavailability ratios. Eur. J. Clin. Pharmacol. 28, 85 (1985)
-
(1985)
Eur. J. Clin. Pharmacol.
, vol.28
, pp. 85
-
-
Steinijans, V.W.1
Diletti, E.2
-
19
-
-
0023874321
-
Comparative bioavailability of furosemide from solution and 40 mg tablets with different dissolution characteristics following oral administration in normal men
-
Waller, E. S., Crismon, M. L., Smith, R. V. et al., Comparative bioavailability of furosemide from solution and 40 mg tablets with different dissolution characteristics following oral administration in normal men. Biopharm. Drug Dispos. 9, 211 (1998)
-
(1998)
Biopharm. Drug Dispos.
, vol.9
, pp. 211
-
-
Waller, E.S.1
Crismon, M.L.2
Smith, R.V.3
-
20
-
-
0021714621
-
Implications of intraindividual variability in bioavailability studies of furosemide
-
Grahnen, A., Hammarlund, M., Lundqvist, T., Implications of intraindividual variability in bioavailability studies of furosemide. Eur. J. Clin. Pharmacol. 27, 595 (1984)
-
(1984)
Eur. J. Clin. Pharmacol.
, vol.27
, pp. 595
-
-
Grahnen, A.1
Hammarlund, M.2
Lundqvist, T.3
-
21
-
-
0025332058
-
Distribution-free procedure for the statistical analysis of bioequivalence studies
-
Hauschke, D., Steinijans, V. W., Diletti, E. A., distribution-free procedure for the statistical analysis of bioequivalence studies. Int. J. Clin. Pharmacol. Ther. Toxicol. 28, 72 (1990)
-
(1990)
Int. J. Clin. Pharmacol. Ther. Toxicol.
, vol.28
, pp. 72
-
-
Hauschke, D.1
Steinijans, V.W.2
Diletti, E.A.3
-
23
-
-
0030748837
-
Comparative bioavailability of two atenolol tablets formulations in healthy male volunteers after a single dose administration
-
Martins, M. L., Pierossi, M. A., Moraes, L. A. et al., Comparative bioavailability of two atenolol tablets formulations in healthy male volunteers after a single dose administration. Int. J. Clin. Pharmacol. Ther. 35, 324 (1997)
-
(1997)
Int. J. Clin. Pharmacol. Ther.
, vol.35
, pp. 324
-
-
Martins, M.L.1
Pierossi, M.A.2
Moraes, L.A.3
-
24
-
-
0021680407
-
Comparative bioequivalence study of furosemide in human volunteers
-
Garg, S. K., Gupta, U., Mathur, V. S., Comparative bioequivalence study of furosemide in human volunteers. Int. J. Clin. Pharmacol. Ther. Toxicol. 22, 618 (1984)
-
(1984)
Int. J. Clin. Pharmacol. Ther. Toxicol.
, vol.22
, pp. 618
-
-
Garg, S.K.1
Gupta, U.2
Mathur, V.S.3
-
25
-
-
0018163138
-
Bioavailability of two furosemide preparations
-
Beermann, B., Dalen, E., Lindstrom, B., Bioavailability of two furosemide preparations. Br. J. Clin. Pharmacol. 6, 537 (1978)
-
(1978)
Br. J. Clin. Pharmacol.
, vol.6
, pp. 537
-
-
Beermann, B.1
Dalen, E.2
Lindstrom, B.3
|